StemProtein, LLC.

StemProtein, LLC. is a leading pharmaceutical manufacturing company dedicated to improving the quality of life for individuals of all ages. Since its founding in 2014 as a subsidiary of Stemedica Cell Technologies, Inc., StemProtein has been at the forefront of manufacturing innovative Stem Cell Factors (SCFs). These SCFs include essential proteins, polysaccharides, and membrane-enclosed vesicles carrying RNA molecules vital for gene regulation.

StemProtein specializes in producing heat-stable SCFs that eliminate the need for refrigeration, making them highly versatile for a wide range of applications. The company's SCFs, derived from ischemic-tolerant mesenchymal stem cells and other proprietary cell lines, are available in powder form, perfectly suited for pharmaceutical use in preventative, health-maintenance, and treatment products. These include nasal sprays, eye drops, intravenous injections, wound dressings, and creams. StemProtein's commitment to quality is evident in its rigorous testing for sterility and endotoxins throughout the manufacturing process, culminating in terminal sterilization via electron beam radiation to ensure the highest safety standards.

StemProtein is actively developing several formulations incorporating its unique heat-stable SCFs, such as wound dressings, mucoadhesive films and tablets, eye drops, nasal sprays, and various skincare products. StemProtein's biologicals demonstrate valuable therapeutic effects, promoting tissue regeneration, new blood vessel formation, prevention of cell death, and inhibition of collagenases, leading to anti-scarring and anti-apoptotic outcomes. We invite the management team at StemProtein to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovations.